Comparison of the Wells score and the revised Geneva score as a tool to predict pulmonary embolism in outpatients over age 65.
Thrombosis Research. 2020-12-01; 196: 120-126
DOI: 10.1016/j.thromres.2020.07.026
Read on PubMed
1. Thromb Res. 2020 Dec;196:120-126. doi: 10.1016/j.thromres.2020.07.026. Epub
2020 Aug 14.
Comparison of the Wells score and the revised Geneva score as a tool to predict
pulmonary embolism in outpatients over age 65.
Coelho J(1), Divernet-Queriaud M(2), Roy PM(3), Penaloza A(4), Le Gal G(5),
Trinh-Duc A(6).
Author information:
(1)Centre Hospitalier d’Agen-Nérac, Site St Esprit, 21 route de Villeneuve,
47923 Agen, France. Electronic address: .
(2)Medical Practice, 748 avenue du Général Leclerc, 47000 Agen, France.
(3)Emergency Department, Centre Hospitalier Universitaire Angers, Institut
Mitovasc, Université d’Angers, Angers, France.
(4)Emergency Department, Cliniques Universitaires St-Luc, Université Catholique
de Louvain, Brussels, Belgium.
(5)Division of Hematology-Thrombosis Program, Department of Medicine, Ottawa
Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
(6)Centre Hospitalier d’Agen-Nérac, Site St Esprit, 21 route de Villeneuve,
47923 Agen, France.
TITLE: Comparison of the Wells score and the revised Geneva score as a tool to
predict pulmonary embolism in outpatients over 65 years of age.
INTRODUCTION: The incidence and mortality of pulmonary embolism (PE) is high in
the elderly. The Wells score (SW) and the revised Geneva score (RGS) have been
validated in patient populations with a large age range. The aim of this study
was to compare the predictive accuracy of these two scores in diagnosis of PE in
patients over 65 years of age.
METHOD: A prospective multicentre study (nine French and three Belgian centres)
was conducted at the same time as the PERCEPIC study. A total of 1757 patients
admitted with suspected PE were included and divided into two groups according
to age (≥65 years or